Muscle weakness, health status and frequency of exacerbations in chronic obstructive pulmonary disease

Postgraduate Medical Journal

Volumn 88, Issue 1041, 2012, Pages 372-376

  Ansari, Khalid ^a   Keaney, Niall ^b   Taylor, Ian ^b   Burns, Graham ^c   Farrow, Malcolm ^d  

^a UNIVERSITY OF SUNDERLAND   (United Kingdom)

^b SUNDERLAND ROYAL HOSPITAL   (United Kingdom)

^c ROYAL VICTORIA INFIRMARY   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DYSPNEA; FEMALE; GRIP STRENGTH; HAND GRIP; HEALTH STATUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MUSCLE WEAKNESS; OBSERVATIONAL STUDY; QUESTIONNAIRE; SCORING SYSTEM; SPIROMETRY; UNITED KINGDOM;

AGED; COHORT STUDIES; DISEASE PROGRESSION; DYSPNEA; ENGLAND; FEMALE; FORCED EXPIRATORY VOLUME; HAND STRENGTH; HEALTH STATUS; HUMANS; MALE; MUSCLE WEAKNESS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUESTIONNAIRES; SPIROMETRY; VITAL CAPACITY;

EID: 84863779109     PISSN: 00325473     EISSN: 14690756     Source Type: Journal    
DOI: 10.1136/postgradmedj-2011-130293     Document Type: Article

References (42)

1. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532-55.
2. Wedzicha JA. Exacerbations: etiology and pathophysiologic mechanisms. Chest 2002;121:136S-41S.
3. Hamilton AL, Killian K, Summers E, et al. Muscle strength, symptom intensity and exercise capacity in patients with cardiorespiratory disorders. Am J Respir Crit Care Med 1995;152:2021-31.
4. Schols AM, Soeters PB, Dingemans AM, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993;147:1151-6.
5. Engelen M, Schols A, Lamers S, et al. Different patterns of chronic tissue wasting among patients with chronic obstructive pulmonary disease. Clin Nutr 1999;18:275-80.
6. Landbo C, Prescott E, Lange P, et al. Prognostic value of nutritional status in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999;160:1856-61.
7. Sue DY. Peripheral muscle dysfunction in patients with COPD, comparing apples to apples? Chest 2003;124:1-4.
8. Sin DD, Man SF. Skeletal muscle weakness, reduced exercise tolerance, and COPD: is systemic inflammation the missing link? Thorax 2006;61:1-3.
9. Decramer M, Lacquet LM, Fagard R, et al. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am Rev Respir Dis 1994;150:11-16.
10. Engelen MP, Schols AM, Baken WC, et al. Nutritional depletion in relation to respiratory and peripheral skeletal muscle functions in out-patients with COPD. Eur Respir J 1994;7:1793-7.
11. Sauleda J, Garci{dotless}́a-Palmer F, Wiesner RJ, et al. Cytochrome oxidase activity and mitochondrial gene expression in skeletal muscle of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1413-17.
12. Bhowmik A, Seemungal TA, Sapsford RJ, et al. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax 2000;55:114-20.
13. Seymour JM, Spruit MA, Hopkinson NS. The prevalence of quadriceps weakness in COPD and the relationship with disease severity. Eur Respir J 2010;36:81-8.
14. Hopkinson NS, Man WC, Dayer MJ, et al. Acute effect of oral steroids on muscle function in chronic obstructive pulmonary disease. Eur Respir J 2004;24:137-42.
15. Bernard S, LeBlanc P, Whittom F, et al. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;158:629-34.
16. Heikkinen E, Waters W,E, Brzezinski ZJ. The Elderly in the Eleven Countries, the Socioeconomic Survey. Copenhagen: WHO, 1993.
17. O'Shea SD, Taylor NF, Paratz J. Peripheral muscle strength training in COPD: a systemic review. Chest 2004;126:903-14.
18. Pipen V, Saey D, Laviolette L, et al. Exercise capacity in chronic obstructive pulmonary disease: mechanisms of limitation. COPD 2007;4:195-204.
19. Rantanen T, Masaki K, Foley D, et al. Grip strength changes over 27 yr. in Japanese-American men. J Appl Physiol 1998;85:2047-53.
20. Quint JK, Bagai-Ravary R, Donaldson GC, et al. Relationship between depression and exacerbations in COPD. Eur Respir J 2008;32:53-60.
21. Decramer M, Gosselink R, Troosters T, et al. Peripheral muscle force is a determinant of survival in COPD [abstract]. Eur Respir J 1998;12:261S.
22. Sayer AA, Syddall HE, Martin HJ, et al. Is grip strength associated with health related quality of life? Findings form the Hertfordshire Cohort Study. Age Ageing 2006;35:409-15.
23. Gosselink R, Troosters T, Decramer M. Distribution of muscle weakness in patients with stable chronic obstructive pulmonary disease. J Cardiopulm Rehabil 2000;20:353-60.
24. Heijdra YF, Pinto-Plata V, Frants R, et al. Muscle strength and exercise kinetics in COPD patients with a normal fat-free mass index are comparable to control subjects. Chest 2003;124:75-82.
25. Rantanen T, Valpato S, Ferrucci L, et al. Hand grip strength and cause of total mortality in older disable women. Am J Geriatr Soc 2003;51:636-41.
26. Ling C, Taekema D, de Craen AJ, et al. Handgrip strength and mortality in the oldest old population: the Leiden 85-plus study. CMAJ 2010;182:429-35.
27. Sunnerhagen KS, Hedberg M, Henning GB, et al. Muscle performance in an urban population sample of 40-to 79-year-old men and women. Scand J Rehabil Med 2000;32:159-67.
28. Lauretani F, Russo CR, Baninelli S, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol 2003;95:1851-60.
29. Ansari K, Shamssain M, Farrow M, et al. Predictors of quality of life in chronic obstructive pulmonary disease patients with different frequency of exacerbations. Pakistan J Med Sci 2007;23:490-6.
30. Fess EE. A method for checking Jamar dynamometer calibration. J Hand Ther 1987;1:28-32.
31. Ashford RF, Nagelburg S, Adkins R. Sensitivity of the Jamar dynamometer in detecting submaximal grip effort. J Hang Surg 1996;21A:402-5.
32. Richards L, Palmiter-Thomas P. Grip strength measurement: a critical review of tools, methods, and clinical utility. Crit Rev Phys Rehabil Med 1996;8:87-109.
33. Jones PW. Measurements of health in asthma and chronic obstructive airway disease. Pharma Med 1992;6:13-22.
34. Celli BR, Marin JM, Casanova C, et al. The body mass index, airflow obstruction, dyspnoea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004;350:1005-12.
35. Atkinson M, Zibin S, Chaung H. Characterizing quality of life among patients with chronic mental illness: a critical examination of the self-report methodology. Am J Psychiatry 1997;154:99-105.
36. Klabunde CN, Reeve BB, Harlan LC, et al. Do patients consistently report comorbid conditions over time? Results from the Prostate Cancer Outcomes Study. Med Care 2005;43:391-400.
37. Quint JK, Donaldson GC, Hurst JR, et al. Predictive accuracy of patient-reported exacerbation frequency in COPD. Eur Respir J 2011;37:501-7.
38. Hurst JR, Vestbo J, Anzeuto A, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med 2010;363:1128-38.
39. Seemungal TA, Donaldson GC, Paul EA, et al. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998;157:1418-22.
40. Remels AH, Gosker HR, van der Velden J. Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity. Clin Chest Med 2007;28:537-5.
41. Wouters EF. Muscle wasting in chronic obstructive pulmonary disease to bother and to measure. Am J Respir Crit Care Med 2006;173:4-5.
42. Agusti A, Calverley P, Celli B. Characterisation of COPD Heterogeneity in the ECLIPSE cohort. Respir Res 2010;11:122.